Research Group Publications

Research Group | Year Index | Home

 Amitabh Joshi Anuranjan Anand Balasubramanian Sundaram C. N. R. Rao 
C. P. Rajendran Chandrabhas Narayana Diwakar S. Venkatesan Eswaramoorthy M.G.U. Kulkarni 
Ganesh Subramanian Govindaraju T H Ila Hemalatha Balaram James P. Clement Chelliah 
Jayanta Haldar K. B. Sinha K.S. Narayan Kanishka Biswas Kaustuv Sanyal 
Kavita Jain Krishnan V.Kundu Tapas K.M. R. S. Rao Maneesha Inamdar 
Meheboob Alam Meher K. Prakash Namita Surolia Narasimha Roddam Rajesh Ganapathy 
Rama Govindarajan Ranjan Datta Ranjani Viswanatha Ravi Manjithaya S. N. Bhat 
Santosh Ansumali Santosh Ansumali Sarit S. Agasti Sebastian C Peter Sheeba Vasu 
Shivaprasad S. M.Shobhana Narasimhan Sreenivas K. R.Sridhar Rajaram Srikanth Sastry 
Subi Jacob George Subir K. Das Sundaresan A.Swapan Pati Tapas Kumar Maji 
Udaykumar Ranga Umesh V. Waghmare Valdiya K. S.Vidhyadhiraja N. S.Vidya T. N. C. 

20162015201420132012201120102009
20082007200620052004200320022001
2000199919981997199619951994Previous
All

  1. Ramana LN, Sharma S, Sethuraman S, Ranga U, Krishnan UM, Evaluation of chitosan nanoformulations as potent anti-HIV therapeutic systems, Biochim Biophys Acta (2013).

  2. Chaudhary S, Bansal C, Ranga U, Singh K, Erythrodermic mycosis fungoides with hypereosinophilic syndrome: a rare presentation, Ecancermedicalscience (2013).

  3. Asokan M, Lone IN, Mukthey AB, Siddhartha P, Mariappa G, Kotehal PK, Satish B, Wilson E, Sahayam S, Velayutham G, Perumal R, Baskaran K, Rengarajan D, Muthusamy R, Philip M, Ravindra KC, Basha JN, Mizar P, Kaur G, Mehra NK, Kundu TK, Subbakrishna DK, Evident stabilization of the clinical profile in HIV/AIDS as evaluated in an open label clinical trial using a polyherbal formulation, Indian J Med Res (2013).

  4. Rao VR, Neogi U, Talboom JS, Padilla L, Rahman M, Fritz-French C, Gonzalez-Ramirez S, Verma A, Wood C, Ruprecht RM, Ranga U, Azim T, Joska J, Eugenin E, Shet A, Bimonte-Nelson H, Tyor WR, Prasad VR., Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence, Retrovirology (2013).

  5. Aiyappan SK, Ranga U, Veeraiyan S, Incidentally detected isolated unilateral pulmonary artery agenesis, J Clin Diagn Res (2013).

  6. Ranga U, Aiyappan SK, Shanmugam N, Veeraiyan S, Ochronotic spondyloarthropathy, J Biol Chem (2013).

  7. Mahadevan A, Ramalingaiah AH, Parthasarathy S, Nath A, Ranga U, Krishna SS, Neuropathological correlate of the "concentric target sign" in MRI of HIV-associated cerebral toxoplasmosis, J Magn Reson Imaging (2013).

  8. Bachu M, Yalla S, Asokan M, Verma A, Neogi U, Sharma S, Murali RV, Mukthey AB, Bhatt R, Chatterjee S, Rajan RE, Cheedarla N, Yadavalli VS, Mahadevan A, Shankar SK, Rajagopalan N, Shet A, Saravanan S, Balakrishnan P, Solomon S, Vajpayee M, Satish KS, Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance, J Biol Chem (2012).

  9. Ranga U, Aiyappan SK, Veeraiyan S, Computed tomography fistulography demonstrating thyroglossal fistula: a case report, Oral Surg Oral Med Oral Pathol Oral Radiol (2012).

  10. Neogi U, Bontell I, Shet A, De Costa A, Gupta S, Diwan V, Laishram RS, Wanchu A, Ranga U, Banerjea AC, Sönnerborg A., Molecular epidemiology of HIV-1 subtypes in India: origin and evolutionary history of the predominant subtype C, PLoS One (2012).

  11. Ramana LN, Sharma S, Sethuraman S, Ranga U, Krishnan UM, Investigation on the stability of saquinavir loaded liposomes: implication on stealth, release characteristics and cytotoxicity, Int J Pharm (2012).

  12. Bachu M, Mukthey AB, Murali RV, Cheedarla N, Mahadevan A, Shankar SK, Satish KS, Kundu TK,Ranga U, Sequence insertions in the HIV type 1 subtype C viral promoter predominantly generate an additional NF-κB binding site, AIDS Res Hum Retroviruses (2012).

  13. Neogi U, Gupta S, Sahoo PN, Shet A, Rao SD, Ranga U, Prasad VR, Genetic characterization of HIV type 1 Tat exon 1 from a southern Indian clinical cohort: identification of unique epidemiological signature residues, AIDS Res Hum Retroviruses (2012).

  14. Gadad SS, Rajan RE, Senapati P, Chatterjee S, Shandilya J, Dash PK, Ranga U, Kundu TK, HIV-1 infection induces acetylation of NPM1 that facilitates Tat localization and enhances viral transactivation, J Mol Biol (2011).

  15. Gadad SS, Senapati P, Syed SH, Rajan RE, Shandilya J, Swaminathan V, Chatterjee S, Colombo E, Dimitrov S, Pelicci PG, Ranga U, Kundu TK, The multifunctional protein nucleophosmin (NPM1) is a human linker histone H1 chaperone, Biochemistry (2011).

  16. Liu Y, Nonnemacher MR, Stauff DL, Li L, Banerjee A, Irish B, Kilareski E, Rajagopalan N, Suchitra JB, Khan ZK, Ranga U, Wigdahl B, Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR, Biomed Pharmacother (2010).

  17. Co-receptor tropism prediction among 1045 Indian HIV-1 subtype C sequences: Therapeutic implications for India, AIDS Res Ther. 7:24, (2010).

  18. Ramana LN, Sethuraman S, Ranga U and Krishnan UM, Development of a liposomal nanodelivery system for nevirapine, J Biomed Sci 17 - 57 (2010).

  19. Madhavi Y, Puliyel JM, Mathew JL, Raghuram N, Phadke A, Shiva M, Srinivasan S, Paul Y, Srivastava RN, Parthasarathy A, Gupta S, Ranga U, Lakshmi VV, Joshi N, Nath I, Gulhati CM, Chatterjee P, Jain A, Priya R, Dasgupta R, Sridhar S, Dabade G, Gopakumar KM,, Abrol D, Santhosh MR, Srivastava S, Visalakshi S, Bhargava A, Sarojini NB, Sehgal D, Selvaraj S, Banerji D and , Evidence-based National Vaccine Policy, Indian J Med Res. 131, 617 - 628 (2010).

  20. Kumar GG, Mahadevan A, Guruprasad AS, Jerry M.E, Kovoor MD, P. Satishchandra, Nath A, Udaykumar Ranga and S.K. Shankar, Eccentric target sign in cerebral toxoplasmosis: neuropathological correlate to the imaging feature, J Magn Reson Imaging. 31, 1469 - 1472 (2010).

  21. Sanchari Bhattacharyya, Roshan Elizabeth Rajan, Yalla Swarupa, Ujjwal Rathore, Anjali Verma, Udaykumar Ranga and Raghavan Varadarajan, Design of a non-glycosylated outer domain derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies, Journal of Biological Chemistry 285, 27100 - 27110 (2010).

  22. Udaykumar Ranga, Akhil Banerjea, Sekhar Chakrabarti, Debashish Mitra., HIV/AIDS research in India-Past, Present and future, Current Science 98 , 335 - 345 (2010). , Reveiw Article.

  23. Udaykumar Ranga, The Saga of the HIV Controversy: Nobel Prize in Physiology or Medicine – 2008, Resonance 14 , 472 - 498 (2010). , Reveiw Article.

  24. Sreenath K, Pavithra L, Singh S, Sinha S, Dash PK, Siddappa NB, Ranga U, Mitra D, Chattopadhyay S., Nuclear Matrix protein SMAR1 represses HIV-1 LTR mediated transcription through chromatin remodeling, Virology 400, 76 - 85 (2010).

  25. Susmita Gurjar, Anita Desai, Mangaiarkarasi A, Udaykumar Ranga, V Ravi, Molecular characterization of a full- length genome of HIV-2 isolate from India, J Acquir Immune Defic Syndr 52 , 329 - 335 (2009).

  26. Venkatesh Prasanna Kashi, Rajesh Abraham Jacob, Siddhartha Paul, Kaustuv Nayak, Soumya Swaminathan, Satish KS, Udaykumar Ranga, HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently Vaccine, Vaccine, 27, 6739 - 6747 (2009).

  27. M. Mishra, S. Vetrivel, N. B. Siddappa, U. Ranga and P. Seth, Clade Specific Neurotoxicity of HIV Tat: Significance of the Dicysteine C30C31 Motif, Annals of Neurology 63, 366 - 376 (2008).

  28. Vasudev R. Rao, Andrew R. Sas, Eliseo A. Eugenin, N. B. Siddappa, Heather Bimonte-Nelson, Joan W. Berman, Ranga U, William R. Tyor and Vinayaka R Prasad,  Human Immunodeficiency Virus-1 Clade-Specific Differences in the Induction of Neuropathogenesis., J. Neurol. Sciences 28, 10010 - 16 (2008).

  29. Prashanta Kumar Dash, Nagadenahalli Byrareddy Siddappa, Asokan Mangaiarkarasi, Aruna V Mahendarkar, Padmanabhan Roshan, Krishnamurthy Kumar Anand,, Anita Mahadevan, Parthasarathy Satishchandra, Susarla K, Vinayaka R Prasad and Ranga U,  ‘Exceptional molecular and coreceptor-requirement properties of molecular clones isolated from an Human Immunodeficiency Virus Type-1 subtype-C infection’ Note: Highly accessed.  http://www.retrovirology.com/content/5/1/25, Retrovirology 5 - 25 (2008).

  30. Mahadevan A, Tagore R, N. B. Siddappa, Santosh V, Yasha TC, Ranga U, Chandramouli BA and Shankar SK, Giant serpentine aneurysm of vertebrobasilar artery mimicking dolichoectasia--an unusual complication of pediatric AIDS. Report of a case with review of the literature., Clin.Neuropathol. 37 - 52 (2008).

  31. Kavitha Y, Thomas S, Damodaran A, Ramakrishna L, Ranga U, Manjunath R., Replication of Japanese encephalitis virus in mouse brain induces alterations in lymphocyte response, Acta Virol., 51, 179 - 87 (2007).

  32. A. Mahadevan, S. K. Shankar, P. Satishchandra, U. Ranga, Y. T. Chickabssavaiah, S. Vani V. Ravi, C. A. Pardo, A. Nath and M. C. Zink, Characterization of Human Immunodeficiency Virus (HIV)-Infected Cells in Infiltrates Associated With CNS Opportunistic Infections in Patients With HIV Clade C Infection, Neuropathology&Experimental Neurology 66, 799 - 808 (2007).

  33. U. Ranga and P. Venkatesh, The HIV-1 Genome: a possible target for control?, HIV/AIDS 153 - 161 (2007).

  34. K. Mantelingu, B. A. Reddy, V. Swaminathan, A. H. Kishore, N. B. Siddappa, G. V. Kumar, G. Nagashankar, N. Natesh, S. Roy, P. P. Sadhale, U. Ranga, C. Narayana and T. K. Kundu, Specific Inhibition of p300-HAT Alters Global Gene Expression andRepresses HIV Replication, Chemistry and Biology 14, 645 - 657 (2007).

  35. N. B. Siddappa, V. P. Kashi, M. Venkatramanan, A. Balasiddaiah, N. Jayasuryan, A. Mahadevan, A. Desai, K. S. Satish, S. K. Shankar, V. Ravi and U. Ranga, Gene Expression Analysis from Human Immunodeficiency Virus Type 1 Subtype C Promoter and Construction of Bicistronic Reporter Vectors, AIDS Research and Human Retroviruses 23, 1268 - 1278 (2007).

  36. N. B. Siddappa, A. Avinash, M. Vekataramanan and U. Ranga, Regeneration of commercial nucleic acid extraction columns without the risk of carryover contamination, BioTechniques 42, 186 - 192 (2007).

  37. A. Mahadevan, P. Satishchandra, K. K. Prachet, N. B. Siddappa, U. Ranga, V. Santosh, T. C. Yasha, A. Desai, V. Ravi and S. K. Shankar, Optic nerve axonal pathology is related to abnormal visual evoked responses in AIDS, Acta Neuropathologica (Berlin) 112, 461 - 469 (2006).

  38. N. B. Siddappa, M. Venkatramanan, P. Venkatesh, N. Jayasuryan, A. Desai, V. Ravi and U. Ranga, Transactivation and signaling functions of Tat are not correlated: biological and immunological characterization of HIV-1 subtype-C Tat protein, Retrovirology 3, 53 - 0 (2006).

  39. N. B. Siddappa, P. K. Dash, A. Mahadevan, A. Desai, N. Jayasuryan, V. Ravi, P. Satishchandra, S. K. Shankar and U. Ranga, Identification of unique B/C recombinant strains of HIV-1 in the Southern State of Karnataka, India, AIDS 19, 1426 - 1429 (2005).

  40. S. K. Shankar, A. Mahadevan, P. Satishchandra, U. Ranga, T. C. Yasha, V. Santosh, A. Chandramuki, V. Ravi and A. Nath, Neuropathology of HIV/AIDS with an overview of the Indian scene, Indian Journal of Medical Research 121, 468 - 488 (2005).

  41. N. B. Siddappa, P. K. Dash, A. Mahadevan, A. Desai, N. Jayasuryan, V. Ravi, P. Satishchandra, S. K. Shankar and U. Ranga, Identification of unique B/C recombinant strains of HIV-1 in the Southern State of Karnataka, India, AIDS 19, 1426 - 1429 (2005).

  42. K. Balasubramanyam, R. A. Varier, M. Altaf, V. Swaminathan, N. B. Siddappa, U. Ranga and T. K. Kundu, Curcumin, a novel p300/CBP-specific inhibitor of acetyltransferase, represses the acetylation of histones/nonhistones proteins and histone acetyltransferase-dependent chromatin transcription, Journal of Biological Chemistry 279, 51163 - 51171 (2004).

  43. L. Ramakrishna, K. K. Anand, K. M. Mohankumar and U. Ranga, Codon optimization of an inherently non-immunodominant HIV-1 antigen generates strong immune responses in mice following genetic immunization, Journal of Virology 78, 9174 - 9189 (2004).

  44. N. B. Siddappa, P. K. Dash, J. Narayana, A. Mahadevan, B. Hoffman, R. Keefe, K. S. Satish, B. Satish, K. Sreekanthan, K. Venu, P. Satishchandra, V. Ravi, S. K. Shankar, R. Shankarappa and U. Ranga, Identification of Subtype C Human Immunodeficiency Virus Type 1 by Subtype-Specific Polymerase Chain Reaction and Its Use in the Characterization of Viruses Circulating in the Southern Parts of India, Journal of Clinical Microbiology 42, 2742 - 2751 (2004).

  45. S. Sinha, T. Mathews, G. R. Arunodaya, N. B. Siddappa, U. Ranga, A. Desai, V. Ravi and A. B. Tally, HIV-1 clade C associated ALS-like disorder: First report from India, Journal of the Neurological Sciences 224, 97 - 100 (2004).

  46. L. Ramakrishna, K. K. Anand, M. Mahalingam, K. M. Mohankumar, R. Shilpa, N. B. Siddappa and U. Ranga, Codon optimization and ubiquitin conjugation of Human Immunodeficiency Virus-1 Tat lead to enhanced cell-mediated immune responses, Vaccine 22, 2586 - 2598 (2004).

  47. U. Ranga, R. Shankarappa, N. B. Siddappa, R. Lakshmi, R. Nagendran, M. Mahalingam, A. Mahadevan, J. Narayana, P. Satishchandra, S. K. Shankar and V. R. Prasad, Tat protein of Human Immunodeficiency Virus Type-1 subtype C viruses is a defective chemokine, Journal of Virology 78, 2586 - 2590 (2004).

  48. Ravi Vijaya Satya, Amer Mukherjee and Udaykumar Ranga, A Pattern Matching Algorithm for Codon Optimization and CpG Motif-Engineering in DNA Expression Vectors, IEEE Conference proceedings 294 (2003).

  49. S. K. Shankar, P. Satishchandra, A. Mahadevan, A. Nalini, U. Ranga, S. Vani, T. C. Yasha and V. Ravi, Neurological Disorders Associated with HIV/AIDS: Asian Perspective, Journal of Neurovirology 9, 13 - 14 (2003).

  50. U. Ranga, Human Immunodeficiency Virus-1 subtypes: Could genetic diversity translate to differential pathogenesis?, Journal of the Indian Institute of Sciences 82, 73 - 91 (2002).

  51. Ranga U, Defining priorities for India. Express Pharma Pulse, HIV/AIDS 28 (2001).

  52. R. Lakshmi, V. Baskar and U. Ranga, Extraction of Superior Quality Plasmid DNA by a Combination of Modified Alkaline Lysis and Silica Matrix, Analytical Biochemistry 272, 109 - 112 (1999).

  53. S. Verma, C. Woffendin, I. Bahner, U. Ranga, L. Xu, Z.-Y. Yang, S. R. King, D. B. Kohn and G. J. Nabel, Gene transfer into human umbilical cord blood-derived CD34+ cells by particle-mediated gene transfer, Gene Therapy 5, 692 - 699 (1998).

  54. U. Ranga, C. Woffendin, S. Verma, L. Xu, C. H. June, D. K. Bishop and G. J. Nabel, Enhanced T cell engraftment after retroviral delivery of an antiviral gene in HIV-infected individuals, Proceedings of the National Academy of Sciences of the United States of America 95, 1201 - 1206 (1998).

  55. U. Ranga, Z.-Y. Yang, L. Xu, D. Littman, C. Woffendin and G. J. Nabel, Cell and viral regulatory elements enhance the efficacy of an HIV inhibitory gene, Journal of Virology 71, 7020 - 7029 (1997).

  56. C. Woffendin, U. Ranga, Z.-Y. Yang, L. Xu and G. J. Nabel, Expression of a protective gene prolongs survival of T cells in human immunodeficiency virus-infected patients, Proceedings of the National Academy of Sciences of the United States of America 93, 2889 - 2894 (1996).

  57. B. A. Fox, C. Woffendin, Z.-Y. Yang, H. San, U. Ranga, D. Gordon, J. Osterholzer and G. J. Nabel, Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity, Human Gene Therapy 6, 997 - 1004 (1995).

  58. C. Woffendin, Z.-Y. Yang, U. Ranga, L. Xu, N.-S. Yang, M. J. Sheehy and G. J. Nabel, Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells, Proceedings of the National Academy of Sciences of the United States of America 91, 11581 - 11585 (1994).

  59. U. Ranga, A. Heredia, V. Soriano, R. Bravo, J. S. Epstein and I. K. Hewlett, Enhanced diagnostic efficiency of the polymerase chain reaction by co-amplification of multiple regions of HIV-1 and HIV-2, Journal of Virological Methods 49, 37 - 46 (1994).

  60. U. Ranga and R. K. Saxena, E. Coli reactive antibody in human tuberculosis sera, Indian Journal of Tuberculosis 41, 29 - 34 (1994).

  61. U. Ranga, J. S. Epstein and I. K. Hewlett, A novel method employing UNG to avoid carry-over contamination in RNA-PCR, Nucleic Acids Research 21, 3917 - 3918 (1993).

  62. U. Ranga and R. K. Saxena, Acid pH induced changes in the immunoreactivity of specific antigen and antibody in circulating immune complexes from tuberculosis sera, Journal of Clinical Laboratory Analysis 6, 194 - 200 (1992).

  63. U. Ranga, R. Sarin and R. K. Saxena, Analysis of Circulating Immune Complexes in tuberculosis: Levels of specific antibody and antigen in CIC and relationship with serum antibody, FEMS Microbiology Immunology 76, 135 - 142 (1991).

  64. U. Ranga and R. K. Saxena, Antigenic epitopes on Mycobacterium tuberculosis recognized by antibodies in tuberculosis and mouse antisera, FEMS Microbiology Immunology 76, 7 - 12 (1991).

Research Units

           

Dean Offices &

Administrative Units

           

Academic Programmes

           

Information for Visitors

           

JNC Quick Links


Other Quick Links

Search Person


Jncasr News   

Announcements